Senores Pharmaceuticals Limited (NSE:SENORES)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Pharmaceuticals	6.33B	3.98B	2.15B	353.37M	141.70M
Total	6.33B	3.98B	2.15B	353.37M	141.70M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India	1.49B	1.05B	474.30M	55.09M	58.33M
outside India	4.84B	2.93B	1.67B	298.28M	83.37M
Total	6.33B	3.98B	2.15B	353.37M	141.70M

Data Source: S&P Global Market Intelligence Last updated: Jul 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error